[Ureteral lesions in radical hysterectomy with pelvic lymph node excision].
[Radical lymph node excision in endometrial carcinoma: the restriction of pelvic irradiation to node-positive cases?].
Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection.
Touijer KA, Vertosick EA, Sjoberg DD, Liso N, Nalavenkata S, Melao B, Laudone VP, Ehdaie B, Carver B, Eastham JA, Scardino PT, Vickers AJ.
Eur Urol. 2025 Feb;87(2):253-260. doi: 10.1016/j.eururo.2024.10.006. Epub 2024 Oct 29.
Clinical Outcomes of Pelvic Lymph Node Dissection Before Versus After Robot-Assisted Laparoscopic Radical Cystectomy.
Wang S, Zhang D, Bai Y, Liu F, Qi X, Xie L.
J Laparoendosc Adv Surg Tech A. 2023 Aug;33(8):776-781. doi: 10.1089/lap.2023.0118. Epub 2023 Jun 1.
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis.
Hinojosa-Gonzalez DE, Nolazco JI, Saffati G, Kronstedt S, Jones JA, Kadmon D, Badal J, Slawin JR.
Eur Urol Focus. 2024 Mar;10(2):234-241. doi: 10.1016/j.euf.2024.01.002. Epub 2024 Jan 18.
Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
Fujimoto N, Shiota M, Tomisaki I, Minato A, Yahara K.
Urol Int. 2019;103(2):125-136. doi: 10.1159/000497280. Epub 2019 Apr 30.
Diagnostic Accuracy of [(18)F]-DCFPyL Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography in Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy: Is Pelvic Lymph Node Dissection Still Necessary?
Eraky A, Tillu N, Ben-David R, Hug B, Jodka H, Agarwal Y, Sur H, Zhou M, Choudhary MK, Mehrazin R, Tewari AK.
J Urol. 2025 Oct;214(4):365-373. doi: 10.1097/JU.0000000000004659. Epub 2025 Jul 7.
Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
Lestingi JFP, Guglielmetti GB, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, Cordeiro MD, Sarkis AS, Faraj SF, Mitre AI, Srougi M, Nahas WC.
Eur Urol. 2021 May;79(5):595-604. doi: 10.1016/j.eururo.2020.11.040. Epub 2020 Dec 5.
Clinical significance of limited and extended pelvic lymph node dissection during robot-assisted radical prostatectomy for patients with localized prostate cancer: A retrospective, propensity score matching analysis.
Hori S, Nakai Y, Tachibana A, Omori C, Nishimura N, Inoue K, Tomizawa M, Shimizu T, Morizawa Y, Gotoh D, Miyake M, Torimoto K, Yoneda T, Fujimoto K, Tanaka N.
Int J Urol. 2023 Feb;30(2):168-175. doi: 10.1111/iju.15075. Epub 2022 Oct 28.
Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy.
Shimbo M, Endo F, Matsushita K, Hattori K.
Int J Urol. 2020 Oct;27(10):845-850. doi: 10.1111/iju.14306. Epub 2020 Jul 7.
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
Ploussard G, Briganti A, de la Taille A, Haese A, Heidenreich A, Menon M, Sulser T, Tewari AK, Eastham JA.
Eur Urol. 2014 Jan;65(1):7-16. doi: 10.1016/j.eururo.2013.03.057. Epub 2013 Apr 6.
Pelvic lymph node dissection in high-risk prostate cancer.
Haiquel L, Cathelineau X, Sanchez-Salas R, Macek P, Secin F.
Int Braz J Urol. 2022 Jan-Feb;48(1):54-66. doi: 10.1590/S1677-5538.IBJU.2020.1063.
